← SynDRA
MRX-2843
SynDRA canonical compound SYN1969796 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | FLT3 | MERTK |
| Mechanism of action | MER tyrosine kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- MER tyrosine kinase inhibitor
- MERTK INHIBITOR
- FLT3 INHIBITOR
Cross-references
Synonyms
- UNC-2371A
- UNII-2MT30EHI63
- 2MT30EHI63
- CHEMBL3326007
- (1r,4r)-4-(2-((2-cyclopropylethyl)amino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol
- UNC2371A
- SCHEMBL14854108
- SCHEMBL17175579
- BDBM350861
- BCP30180
- BDBM50055490
- MFCD28502224
- ZINC299829706
- CS-8117
- SB17283
- AS-35252
- HY-101549
- US9795606, B20
- A16958
- UNC2371;UNC-2371;UNC 2371;MRX 2843 ;MRX2843
- Cyclohexanol, 4-(2-((2-cyclopropylethyl)amino)-5-(4-((4-methyl-1-piperazinyl)methyl)phenyl)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-, trans-
- trans-(1R,4R)-4-(2-((2-cyclopropylethyl)amino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol
- trans-4-(2-((2-Cyclopropylethyl)amino)-5-(4-((4-methyl-1-piperazinyl)methyl)phenyl)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)cyclohexanol
Look up MRX-2843 in the interactive SynDRA portal →